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The sustainable development goals agreed in March 2016 by
the United Nations General Assembly set the global
development agenda for the next 15 years. They include an
ambitious target to reduce premature mortality from
non-communicable diseases by a third by 2030. Premature
mortality, defined by the World Health Organization as deaths
occurring between the ages of 15 and 70, has gained broad
acceptance in health research and policy over the past decade.
We argue that it is explicitly ageist, reflecting institutional
ageism in global health policy. Its inclusion in the sustainable
development goals sends a strong signal in favour of
discriminating against older people in the allocation of health
resources and the collection of data.We consider the emergence
of ageist approaches in global health policy and the potential
effects of ageism in the sustainable development goals. We
propose a less discriminatory approach.
Institutional ageism
Ageism is defined as: “a process of systematic stereotyping and
discrimination against people because they are old.”1
Institutional ageism differs from, but is related to, interpersonal
ageism. It involves the inclusion of ageist principles in formal
rules and procedures and in wider institutional cultures. It is
characterised by language consistently depicting older people
in negative terms.2
Less research has been done on ageism than on other forms of
discrimination, such as racism and sexism. Studies of
institutional ageism have mainly explored discrimination in
employment and the workplace,3 and few studies explicitly
examine its role in health. Most of the health studies focus on
specific groups, such as older people who are lesbian, gay, or
bisexual or racial minorities.4
Several arguments have been used to justify age discrimination
in health policy. The “fair innings” argument posits that
everyone is entitled to a certain quality adjusted life expectancy
and so policies should prioritise interventions that deliver this,
even if they often favour younger people.5Accordingly, ageism
may be fundamentally different to discrimination based on
gender or race since it redresses existing disadvantage. Of
course, there is the vexed question of how many years might
be considered a “fair innings”: something that would require
informed debate and social consensus among people of all ages
before being adopted. More generally, these justifications for
age discrimination contradict the universal principle of health
as a fundamental right for all.
Other arguments for age discrimination draw on concepts of
human capital and efficiency. These claim that older people
make fewer contributions to society than younger adults and
thus have less social and economic value.6 This links to
stereotypes equating old age with frailty, weakness, and
dependency, which are contradicted by evidence that many older
adults make substantial economic and social contributions.7 8 It
is sometimes observed that older people’s health problems are
relatively expensive to treat and that interventions generate few
returns.9 10 Yet many conditions affecting older people can be
treated cheaply, substantially extending healthy life expectancy.11
Epidemiological roots of ageism: from
YLLs to DALYs
Simple measures of overall mortality are skewed towards
conditions that disproportionately kill older people, since most
deaths occur in later life.12 This could unfairly understate
conditions affecting younger age groups. To take account of
this, the years of potential life lost (YLL) approach to measuring
mortality was developed in the 1980s.13YLLsweight the burden
of mortality according to the number of years between the age
at which death occurs and an arbitrary age threshold in later
life, typically somewhere between 65 and 80. Averting the death
of a person over that age is given a value of zero.
YLLs have been widely applied in research and health policy,
with a range of threshold ages. However, they raise ethical and
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practical problems, including where to set the age threshold
beyond which any added life years are deemed worthless.
Although proponents of YLLs may not advocate that the value
of survival beyond a certain age should literally be understood
as worthless, the approach frames thinking in this ageist
direction.
In 1993 theWorld Bank andWHO launched disability adjusted
life years (DALYs) as a tool for studying patterns of disease
and assessing health priorities.14 DALYs apply a disability
weight to remaining years of life, up to a fixed YLL age
threshold. Originally DALYs applied an additional weighting
according to the age at which each year of life was lost: a year
lost in childhood or old age was worth much less than for other
ages. For example, the value given to a year lived at age 70 was
less than half one at age 25. It was argued: “The young, and
often the elderly, depend on the rest of society for physical,
emotional and financial support. Given different roles and
changing levels of dependency with age, it may be appropriate
to consider valuing the time lived at a particular age unequally.”6
The only evidence used to justify age weighting was an
“informal polling of tuberculosis programme managers,” and
no evidence was produced to justify the strength of the age
weights. Several studies noted that DALY age weighting and
the Global Burden of Disease unfairly undervalued conditions
mainly affecting older people.15-17 Yet age weighting continued
in the Global Burden of Disease studies until 2010.
Global priorities and older people
By 1960 roughly half the global population aged 60 or over
lived in low and middle income countries, rising to two thirds
by 2015. Despite this shift, until the 1990s research and policy
discussion about older people’s health took place almost
exclusively in high income countries.18 There has been some
growth in geriatric research and practice in low and middle
income countries since, but global policy priorities have
remained heavily focused on other issues, such as infectious
disease and reproductive health. In the case of HIV/AIDS,WHO
and UNAIDS supported the collection of prevalence data only
for people aged 15-49.
The slow response of the global health community to
demographic change reflects several factors, including the
influence of UN agencies and non-governmental organisations
interested in specific issues and other population groups. At the
same time, agencies interested in older people in low andmiddle
income countries mainly focused on the extension of pension
provision.19Embryonic international networks for older people’s
health struggled to influence the wider global discourse and
sometimes lacked awareness of ageism in global policy. For
example, the UN’s 2002 Madrid International Plan of Action
on Ageing makes no reference to bias against older people in
DALYs.20
The neglect of older people was paralleled by the low priority
given to non-communicable diseases (NCDs). This resulted
from a misperception that these diseases mainly affect wealthy
people and sustained resistance from related industries.21Ageism
may have contributed to this neglect, inasmuch as NCDs are
viewed as primarily “conditions of older age.” From 2000, when
WHO published its first global strategy for prevention and
control of NCDs, an influential global network began to promote
them as a development concern.22 23 Potentially, this represented
an opportunity to improve recognition of older people’s health,
but the network took a different line. Many WHO documents
and publications on NCDs make no reference to older people,
or merely identify population ageing as a “driver” of NCD
pandemics.24 They emphasise the effect of these diseases on
younger adults to justify giving them a higher priority than
conditions mainly affecting older people. For example,WHO’s
2008-13 Action Plan for the Prevention and Control of NCDs
refers to gender, race, and people with disabilities but not to
older people.24 Six of the 27 key NCD indicators that WHO
advocates member states should prioritise, including tobacco
use and raised blood pressure, are limited to people aged 25 to
64. No reasons are provided for these age limits.
Premature mortality: a new form of
institutional ageism?
From 2008 the concept of premature mortality started to gain
widespread acceptance among global agencies. In part, this was
driven by concerns about the economic effects of disease,
especially on people of “working age” and the view that scarce
resources should focus on preventing death at younger ages.
The foreword of WHO’s 2008-13 action plan claims that
reducing premature mortality from NCDs could save millions
of lives, but the term is not defined and is not mentioned in the
rest of the plan.24 By contrast, premature mortality took centre
stage in the 2010 global status report on NCDs. It is defined as
mortality below the age of 70, lowering the threshold age of
zero utility applied by DALYs by more than 10 years without
any justification.25
The 2010WHO report was the reference document for the 2011
UN high level meeting on NCDs, a political declaration, and a
plan ratified by the 2013 World Health Assembly. The plan
commits to reducing premature mortality from cardiovascular
disease, diabetes, cancers, and respiratory disease by 25%
between 2010 and 2025 and has already influenced national
policies.26 Amodified version of the premature mortality target
was included in the sustainable development goals: “by 2030
reduce by one-third premature mortality from NCDs through
prevention and treatment.” The goals do not define premature
mortality but presumably refer to WHO’s under 70 threshold.
While such global targets do not always translate directly into
national policy, they are influential.27 These targets are therefore
likely to promote institutional ageism in several ways,
discouraging research and data collection, focusing resources
on younger people, and exacerbating existing discrimination.
The potential effect on research and data collection is shown
by the earlier exclusion of older people from HIV targets. In
2010, fewer than half UNAIDS national HIV progress reports
included data on people aged over 50.28 A review of clinical
trials on reducing the risk of sexually transmitted diseases found
that over two thirds excluded people aged 50 or over.29 There
is already evidence that older people are also excluded from
studies of NCDs and from randomised controlled trials, making
findings potentially inapplicable to them.30 A growing number
of epidemiological studies apply the 70 and over premature
mortality threshold.31-33
The challenges of reducing premature mortality from NCDs by
a third are substantial, requiring a large reallocation of resources
away from older people. Advocates of prematuremortality argue
early life interventions ultimately benefit people of all ages, but
this approach excludes people currently aged 70 or over.34
Use of the term premature mortality exacerbates and justifies
existing age discrimination in healthcare11 35 by implying that
survival after the age of 70 is fundamentally less important than
survival at younger ages. It also distracts attention from major
challenges that especially affect older people, including
multimorbidity and palliative care.36
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Redressing the balance
Since the 1990s key aspects of health policy have been framed
by ageist principles. The arguments used to justify age
discrimination are evidently invalid. The prominent role given
to prematuremortality thresholds shows that ageism is becoming
increasingly blatant. It is inconceivable that global targets would
similarly discriminate against other groups, such as women or
people with disabilities.
Engaging with ageism in health policy does not mean throwing
the baby out with the bathwater. We still need mortality
indicators such as YLLs, but they must be interpreted with care.
Additionally, policy makers should explicitly assess how the
choice of measure affects the priority given to each age group.
Highly cost effective health interventions exist for people of all
ages. Improved surveillance increases the scope to capture the
disease burden in older people. For example, promoting
awareness and management of hypertension can substantially
reduce preventable deaths and disability.37 In 2015 WHO
published a major report on ageing and health,36 indicating that
it is ready to jettison ageist concepts and champion a more
ethical approach. Such progress must not be undermined by
poorly considered global targets.
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Key messages
Despite growing numbers of people aged over 60 in low and middle income countries, health priorities remain focused elsewhere
The target in the sustainable development goals to reduce premature mortality from non-communicable diseases reflects wider ageism
in global health policy
Policy makers should consider how the choice of measure affects the priority given to each age group
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